Cargando…

Sugammadex for reversing neuromuscular blockages after lung surgery: A systematic review and meta-analysis

This study determined whether sugammadex was associated with a lower risk of postoperative pulmonary complications and improved outcomes in lung surgeries. METHODS: A systematic literature search was conducted using PubMed, Embase, Web of Science, and the Cochrane Library from January 2000 to March...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jia-Li, Chen, Kuen-Bao, Shen, Mei-Ling, Hsu, Wei-Ti, Lai, Yu-Wen, Hsu, Chieh-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524927/ https://www.ncbi.nlm.nih.gov/pubmed/36181093 http://dx.doi.org/10.1097/MD.0000000000030876

Ejemplares similares

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China
por: Ren, Maodong, et al.
Publicado: (2020)

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
por: Carron, Michele, et al.
Publicado: (2017)

A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block
por: Koo, Chang-Hoon, et al.
Publicado: (2020)

Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors
por: Quang, Thuy Luu, et al.
Publicado: (2019)

Association of neuromuscular reversal by sugammadex and neostigmine with 90-day mortality after non-cardiac surgery
por: Oh, Tak Kyu, et al.
Publicado: (2020)

Effect of neuromuscular reversal with neostigmine/glycopyrrolate versus sugammadex on postoperative ileus following colorectal surgery
por: Traeger, L., et al.
Publicado: (2022)

Sugammadex and Reversal of Neuromuscular Block in Adult Patient with Duchenne Muscular Dystrophy
por: Wefki Abdelgawwad Shousha, Ahmed Abdelgawwad, et al.
Publicado: (2014)

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
por: Schaller, Stefan Josef, et al.
Publicado: (2013)

Reversal of neuromuscular block with sugammadex in five heart transplant pediatric recipients
por: Carlos, Ricardo Vieira, et al.
Publicado: (2017)

Reversal by Sugammadex
por: Bajaj, Pramila
Publicado: (2009)

The influence of mild hypothermia on reversal of rocuronium-induced deep neuromuscular block with sugammadex
por: Lee, Hee Jong, et al.
Publicado: (2015)

Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: A systematic review and meta-analysis
por: Won, Young Ju, et al.
Publicado: (2016)

Postoperative pulmonary complications after sugammadex reversal of neuromuscular blockade: a systematic review and meta-analysis with trial sequential analysis
por: Liu, Hong-Mei, et al.
Publicado: (2023)

Sensitivity to Rocuronium-Induced Neuromuscular Block and Reversibility with Sugammadex in a Patient with Myotonic Dystrophy
por: Kashiwai, Akihiro, et al.
Publicado: (2012)

Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
por: Suzuki, Manzo, et al.
Publicado: (2014)

Sugammadex, a Neuromuscular Blockade Reversal Agent, Causes Neuronal Apoptosis in Primary Cultures
por: Palanca, José M., et al.
Publicado: (2013)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013)

Sugammadex to Reverse Neuromuscular Blockade in a Child with a Past History of Cardiac Transplantation
por: Miller, Karen, et al.
Publicado: (2017)

Sugammadex to reverse neuromuscular blockade and provide optimal conditions for motor-evoked potential monitoring
por: Trifa, Mehdi, et al.
Publicado: (2017)

Update on the management of neuromuscular block: focus on sugammadex
por: de Boer, Hans D, et al.
Publicado: (2007)

Sugammadex: A revolutionary drug in neuromuscular pharmacology
por: Nag, Kusha, et al.
Publicado: (2013)

The effect of neuromuscular reversal agent on postoperative pain after laparoscopic gastric cancer surgery: Comparison between the neostigmine and sugammadex
por: Oh, Tak Kyu, et al.
Publicado: (2019)

Limited advantage of sugammadex reversal over the traditional neuromuscular reversal technique in terms of postoperative recovery of bowel function
por: Kim, Duk Kyung
Publicado: (2020)

Efficacy and safety of sugammadex sodium in reversing rocuronium-induced neuromuscular blockade in children: An updated systematic review and meta-analysis
por: Zhou, Sheng, et al.
Publicado: (2023)

Required dose of sugammadex or neostigmine for reversal of vecuronium‐induced shallow residual neuromuscular block at a train‐of‐four ratio of 0.3
por: He, Jing, et al.
Publicado: (2021)

Influence of sugammadex versus neostigmine for neuromuscular block reversal on the incidence of postoperative pulmonary complications: a meta-analysis of randomized controlled trials
por: Wang, Jia-Feng, et al.
Publicado: (2021)

Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine.
por: Lemmens, Hendrikus JM, et al.
Publicado: (2010)

Reversal with sugammadex for rocuronium-induced deep neuromuscular block after pretreatment of magnesium sulfate in rabbits
por: Kang, Woon Seok, et al.
Publicado: (2017)

The effect of magnesium on the reversal of rocuronium-induced neuromuscular block with sugammadex: an ex vivo laboratory study
por: Fábián, Ákos I., et al.
Publicado: (2019)

Should we Routinely Reverse Neuromuscular Blockade with Sugammadex in Patients with a History of Heart Transplantation?
por: Yuki, Koichi, et al.
Publicado: (2020)

Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain
por: Martinez-Ubieto, J., et al.
Publicado: (2021)

An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant
por: Paredes, Stephania, et al.
Publicado: (2023)

Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis
por: Lang, Bingchen, et al.
Publicado: (2022)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
por: Cheong, Soon Ho, et al.
Publicado: (2015)

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
por: Aouad, Marie T., et al.
Publicado: (2017)

Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome
por: Ledowski, Thomas, et al.
Publicado: (2013)

Reversal of rocuronium induced neuromuscular blockade using sugammadex in a patient with eclampsia treated by magnesium intraoperatively
por: Song, Sejin, et al.
Publicado: (2014)

Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction
por: de Boer, Hans D, et al.
Publicado: (2018)

Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature
por: Fernandes, Hermann dos Santos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uprhacrtufr49jmcg4otfqcesm